Cormorant Asset Management, Lp Apellis Pharmaceuticals, Inc. (APLS) insider trading activity

Cormorant Asset Management, LP is > 10% Shareholder of Apellis Pharmaceuticals, Inc.. Currently has a direct ownership of 3.47 Million shares of APLS, which is worth approximately $115 Million. The most recent transaction as insider was on Nov 13, 2017, when has been sold 1,071,428 shares (Common Stock) at a price of $14.0 per share, resulting in proceeds of $14,999,992. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).